Even though more researches are still needed, these results illustrated that NR1H4 is a negative regulator in liver cell proliferation and provides a new insight of HDACi for treatment in cancer that targeting NR1H4-SOCS2 signaling. This evidence concerns the gene SOCS2 and cancer.